Why SIGA fell 16% since Nov 9
Down 16% from Nov 9 to Nov 17 while the S&P 500 fell 3%.
- Its Nov 9 results:
Down 16% from Nov 9 to Nov 17 while the S&P 500 fell 3%.
SIGA's Quality Score rose 2 points on Wed, Nov 18, to -3.
Follow SIGA's trial news. Pro members can get an alert when SIGA Technologies files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| Since its 2022 high | Down 90% |
| Latest filing | 8-K, Nov 9 |
After its last 4 reports it closed -2.0% on average, higher 1 of 4 times.
$116M in cash
No shelf registration or at-the-market program on file in the last three years.
No open-market buys or sales by its officers or directors in their filings of the last year.
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
Poorfor quality, not price, 4 of 14 chart checks firingWhat the Quality Score means
SIGA is #71 of 89 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 71 |
Expected to report Tue Mar 9, after the close (in 111 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
A loss of $0.04 a share.
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Research and Development | $1.1M | $3.1M | $1.7M |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 9)
No outlook figures read from this release.
Sales fell 5.4% a year over 5 years, fiscal 2020 to 2025.
Its share count fell 2% a year over 5 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 9, 2026 | -6.8% | -4.0% | -12.6% |
| Aug 6, 2026 | +1.0% | -2.2% | -7.7% |
| May 7, 2026 | -2.0% | +1.5% | -9.9% |
Sales grew in three of the last seven years, to $94.6M in 2025. It made a profit in seven of the eight years.
RSI 40.7, MACD below signal, below both averages. Not scored.
Officers and directors with a Form 4 in the last 12 months.
In ETFs: SIGA is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
“The biotechnology and pharmaceutical industries are characterized by rapidly evolving technology and intense competition.”
SIGA scores -3 today, which Breakaway calls Poor. It is #71 of 89 in Pharma by Quality Score, with 4 of 14 chart checks firing. Down 16% from Nov 9 to Nov 17 while the S&P 500 fell 3%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
SIGA scores -3 today, which Breakaway calls Poor (below zero). That is #71 of 89 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind SIGA's -3.
Expected to report Tue Mar 9, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. SIGA closed higher after 1 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Friday morning. No account. No card. Then keep going with a free account.Then 7 days of Pro free, with a card.